Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 10, 2025 08:00 ET | Source: RENAISSTHERA PRIVATE LIMITED

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

BENGALURU, India, June 10, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery...
June 09, 2025 23:30 ET | Source: RENAISSTHERA PRIVATE LIMITED

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

BENGALURU, India, June 09, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (“RenaissThera”), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery...
January 08, 2025 11:23 ET | Source: International Food Information Council Foundation

Americans Weigh In: International Food Information Council Releases New Research Examining Perceptions Around Obesity & Weight Loss Medications

Washington, DC, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The International Food Information Council (IFIC) has published a new survey examining Americans’ attitudes and perceptions toward obesity...
July 22, 2024 13:29 ET | Source: SNS Insider pvt ltd

Weight Loss Drugs Market Size to Hit US$ 45.35 Billion By 2032, With a Growing CAGR of 43.73% | Research by SNS Insider

Pune, July 22, 2024 (GLOBE NEWSWIRE) -- Weight Loss Drugs Market Size & Growth Analysis: “According to SNS Insider Research, The Weight Loss Drugs Market size is valued at US$ 1.92 Billion...
January 23, 2023 09:30 ET | Source: Medi-Tech Insights

Global Obesity Drugs Market valued at $2.3 billion (2022), is Projected to Witness a Significant Growth Rate of 25% by 2027

BRUSSELS, BELGIUM, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Obesity and overweight are defined as accumulation of excessive or abnormal fat leading to increased risk to health, which can be measured by...
September 07, 2016 08:00 ET | Source: Researchmoz Global Pvt Ltd

Global Diabetes and Obesity Drugs Market to reach $163.2 Billion by 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment: ResearchMoz

Albany, NY, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Diabetes is a chronic metabolic disease characterized by hyperglycemia (high blood glucose levels) that results from defects in insulin secretion,...
January 07, 2015 08:08 ET | Source: Obesity Medicine Association

Sticking to Your New Year's Weight Resolution

DENVER, Jan. 7, 2015 (GLOBE NEWSWIRE) -- It's no secret that most people want to lose weight this time of year. But even if the weight comes off easily, there's still the life-long struggle to...